Prosecution Insights
Last updated: August 17, 2026

Examiner: LOCKARD, JON MCCLELLAND

Tech Center 1600 • Art Units: 1647

This examiner grants 75% of resolved cases

Performance Statistics

74.7%
Allow Rate
+14.7% vs TC avg
872
Total Applications
+27.0%
Interview Lift
896
Avg Prosecution Days
Based on 853 resolved cases, 2023–2026

Rejection Statute Breakdown

5.9%
§101 Eligibility
12.5%
§102 Novelty
8.1%
§103 Obviousness
51.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19431026 ANTI-CACFD1 (CALCIUM CHANNEL FLOWER DOMAIN CONTAINING 1) ANTIBODIES AND USES THEREOF Non-Final OA FITNESS FINGERPRINT THERAPEUTICS
17758094 A METHOD OF ENGINEERING NATURAL KILLER CELLS TO TARGET CD70-POSITIVE TUMORS Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18685045 CELL-SURFACE ANTIBODY TO A SPECIFIC BIOMARKER OF PANCREATIC BETA-CELLS Non-Final OA THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
17988893 MAdCAM-1 POLYPEPTIDES AND USES THEREOF Non-Final OA Ramot at Tel-Aviv University Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month